Therapeutic strategies

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Analysis antibody applied approach BMI body mass body mass index C-reactive protein cardiometabolic cardiometabolic exposure cardiometabolic risk factor Cardiometabolic risk factors caused circulating Circulating proteins conducted contribute coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 disease COVID-19 progression COVID19 Critical cytokine Cytokines determine Developing disease Effect evaluate the effect Evaluating Evidence evidence of example finding foundation functions funding Future Genetic genomic location global pandemic glycoprotein heart help highlight host protein host response Immunoglobulin Immunoglobulin G independent Infection Inflammatory marker inflammatory markers Inflammatory response initial Innovation interleukin interleukin-6 involved IVW Medical Research Council mendelian randomization multiple testing Multivariable MR overcome Pathogenesis predicted progression proportion Protein provided raised receptor receptor antagonist replicate Research respiratory responsible risk risk factor Risk factors robust SARS-CoV-2 SARS-COV-2 infection sensitivity severe acute respiratory syndrome Coronavirus severe COVID-19 disease severe SARS severe SARS-CoV-2 smoking Standard deviation systemically the strongest Therapeutic strategies therapeutic strategy Triglyceride triglycerides turn variant variety Wellcome Trust
[DOI] 10.1016/j.ebiom.2021.103228 PMC 바로가기 [Article Type] Research Paper